432 Results

People

  1. Old
    Old
  2. Wolchok
    Wolchok
  3. Houghton
    Houghton
  4. Gnjatic
    Gnjatic
  5. Allison
    Allison
  6. Ritter
    Ritter
  7. Merghoub
    Merghoub
  8. Jungbluth
    Jungbluth
  9. Yuan
    Yuan
  10. Perales
    Perales

Groups

  1. Department of Medicine (218)
  2. GSK Faculty (208)
  3. Sloan Kettering Institute Faculty (138)
  4. Sloan Kettering Institute Postdocs (132)
  5. Solid Tumor Oncology Division (131)
  6. Hematologic Malignancies, Division of (116)
  7. Center for Hematologic Malignancies (98)
  8. Immunology Program Faculty (97)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (78)
  10. Department of Pathology and Laboratory Medicine (73)
  1. "cd8+ t lymphocyte"
Formats
  1. Journal Article (390)
  2. Review (20)
  3. Editorial (18)
  4. Research Letter (3)
  5. Miscellaneous (1)
Groups
  1. Department of Medicine (218)
  2. GSK Faculty (208)
  3. Sloan Kettering Institute Faculty (138)
  4. Sloan Kettering Institute Postdocs (132)
  5. Solid Tumor Oncology Division (131)
  6. Hematologic Malignancies, Division of (116)

More Groups

People
  1. Jedd Wolchok (55)
  2. Lloyd Old (39)
  3. Alan Houghton (27)
  4. Sacha Gnjatic (26)
  5. Taha Merghoub (26)
  6. Gerd Ritter (23)

More People

Years
  1. 2025 (30)
  2. 2024 (49)
  3. 2023 (35)
  4. 2022 (29)
  5. 2021 (17)
  6. 2020 (22)

More Years

Publications
  1. Blood (23)
  2. Journal of Immunology (21)
  3. Clinical Cancer Research (20)
  4. Nature (19)
  5. PLoS ONE (14)
  6. Proceedings of the National Academy of Sciences of the United States of America (14)

More Publications

Publishers
  1. Nature Publishing Group (73)
  2. American Association for Cancer Research (40)
  3. American Society of Hematology (30)
  4. Elsevier Inc. (29)
  5. Cell Press (27)
  6. The American Association of Immunologists, Inc (21)

More Publishers

Results (432)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neoantigen-directed immune escape in lung cancer evolution
    Journal Article

    Rosenthal, R.; Cadieux, E. L.; Salgado, R.; Al Bakir, M.; Moore, D. A.; Hiley, C. T.; Lund, T.; Tanić, M.; Reading, J. L.; Joshi, K.; more...
    Nature (2019)

    Fulltext@MSK | Save
  • PEGylated IL-10 (pegilodecakin) induces systemic immune activation, CD8(+) T cell invigoration and polyclonal T cell expansion in cancer patients
    Journal Article

    Naing, A.; Infante, J. R.; Papadopoulos, K. P.; Chan, I. H.; Shen, C.; Ratti, N. P.; Rojo, B.; Autio, K. A.; Wong, D. J.; Patel, M. R.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: A report on the successful treatment of a rare malignancy
    Journal Article

    Lattanzi, M.; Deng, F. M.; Chiriboga, L. A.; Femia, A. N.; Meehan, S. A.; Iyer, G.; Voss, M. H.; Sundatova, Y.; Huang, W. C.; Balar, A. V.
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Beyond cell death: New functions for TNF family cytokines in autoimmunity and tumor immunotherapy
    Journal Article

    Yi, F.; Frazzette, N.; Cruz, A. C.; Klebanoff, C. A.; Siegel, R. M.
    Trends in Molecular Medicine (2018)

    Fulltext@MSK | Save
  • Differential association between circulating lymphocyte populations with outcome after radiation therapy in subtypes of liver cancer
    Journal Article

    Grassberger, C.; Hong, T. S.; Hato, T.; Yeap, B. Y.; Wo, J. Y.; Tracy, M.; Bortfeld, T.; Wolfgang, J. A.; Eyler, C. E.; Goyal, L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • Immune biomarkers predictive for disease-free survival with adjuvant sunitinib in high-risk locoregional renal cell carcinoma: From randomized phase III S-TRAC study
    Journal Article

    George, D. J.; Martini, J. F.; Staehler, M.; Motzer, R. J.; Magheli, A.; Escudier, B.; Gerletti, P.; Li, S.; Casey, M.; Laguerre, B.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Non-conventional inhibitory CD4(+)Foxp3(−)PD-1(hi) T cells as a biomarker of immune checkpoint blockade activity
    Journal Article

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M. A.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Liu, C.; Zhong, H.; Li, Y.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: Phase 1 results and long-term follow-up
    Journal Article

    Kreitman, R. J.; Tallman, M. S.; Robak, T.; Coutre, S.; Wilson, W. H.; Stetler-Stevenson, M.; FitzGerald, D. J.; Santiago, L.; Gao, G.; Lanasa, M. C.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • TGF-β inhibition and immunotherapy: Checkmate
    Journal Article

    Ganesh, K.; Massagué, J.
    Immunity (2018)

    Fulltext@MSK | Save
  • TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
    Journal Article

    Mariathasan, S.; Turley, S. J.; Nickles, D.; Castiglioni, A.; Yuen, K.; Wang, Y.; Kadel, E. E. 3rd; Koeppen, H.; Astarita, J. L.; Cubas, R.; more...
    Nature (2018)

    Fulltext@MSK | Save